James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 6,999 shares at $56.95 ($399K) on 2019-07-08, disclosed to the SEC on 2019-07-09.
Open-market sale of $399k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.95 | 1,300 | $74K | 18.5% |
| 2 | $56.95 | 2,499 | $142K | 35.7% |
| 3 | $56.95 | 2,499 | $142K | 35.7% |
| 4 | $57.74 | 200 | $12K | 2.9% |
| 5 | $57.85 | 501 | $29K | 7.3% |
| Total | $57.04 avg | 6,999 |
| $399K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $362K | — | Filing → |